Takai, Shinji <br/><br/>
Activation of phosphatidylinositol 3-kinase/Akt limits FGF-2-induced VEGF release in osteoblasts.  [electronic resource] 

 -  Molecular and cellular endocrinology  Mar 2007 
 - 46-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0303-7207 
<br/><br/><label>Standard No.: </label>10.1016/j.mce.2006.12.036  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androstadienes--pharmacology<br/>Animals<br/>Cells, Cultured<br/>Chromones--pharmacology<br/>Dactinomycin--pharmacology<br/>Enzyme Activation--drug effects<br/>Fibroblast Growth Factor 2--pharmacology<br/>Flavonoids--pharmacology<br/>Glycogen Synthase Kinase 3--metabolism<br/>Glycogen Synthase Kinase 3 beta<br/>JNK Mitogen-Activated Protein Kinases--metabolism<br/>Mice<br/>Mice, Inbred BALB C<br/>Mitogen-Activated Protein Kinase 1--metabolism<br/>Morpholines--pharmacology<br/>Osteoblasts--drug effects<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Phosphorylation--drug effects<br/>Proto-Oncogene Proteins c-akt--antagonists & inhibitors<br/>Vascular Endothelial Growth Factor A--metabolism<br/>Wortmannin